Literature DB >> 15076731

Long-term methylphenidate treatment down-regulates c-fos in the striatum of male CD-1 mice.

Christianne M Hawken1, Richard E Brown, Normand Carrey, Michael Wilkinson.   

Abstract

Methylphenidate (Ritalin) is routinely prescribed to children with attention deficit hyperactivity disorder, but little is known about its long-term consequences on brain development. We treated pre- and peri-pubertal male CD-1 mice with repeated injections of methylphenidate hydrochloride (MPH) and quantified the expression of the immediate early gene c-fos in the striatum. A single injection of MPH (5 or 40 mg/kg) significantly elevated FOS immunoreactivity in the striatum in a dose-dependent manner, compared with saline. Repeated MPH treatment attenuated the effect of a single challenge dose of MPH on striatal c-fos expression. These results replicate those observed with rats and indicate that long-term use of MPH may alter neural activity by down-regulation of gene expression in the striatum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076731     DOI: 10.1097/00001756-200404290-00022

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

Review 1.  A review of psychostimulant-induced neuroadaptation in developing animals.

Authors:  Normand Carrey; Michael Wilkinson
Journal:  Neurosci Bull       Date:  2011-06       Impact factor: 5.203

2.  Methylphenidate modulates the locus ceruleus neuronal activity in freely behaving rat.

Authors:  Bin Tang; Nachum Dafny
Journal:  Eur J Pharmacol       Date:  2012-09-18       Impact factor: 4.432

3.  Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.

Authors:  Amy K Wagner; Laura L Drewencki; Xiangbai Chen; F Ryan Santos; Amina S Khan; Rashed Harun; Gonzalo E Torres; Adrian C Michael; C Edward Dixon
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

4.  Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission.

Authors:  Amy K Wagner; Joshua E Sokoloski; Xiangbai Chen; Rashed Harun; Damian P Clossin; Amina S Khan; Meghan Andes-Koback; Adrian C Michael; C Edward Dixon
Journal:  J Neurochem       Date:  2009-05-08       Impact factor: 5.372

Review 5.  Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.

Authors:  Heinz Steiner; Vincent Van Waes
Journal:  Prog Neurobiol       Date:  2012-10-17       Impact factor: 11.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.